Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. 1999

M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
Department of Neurology, College of Physicians & Surgeons, Columbia University, Columbia-Presbyterian Medical Center, New York, NY 10032, USA.

Mutations in the human alpha-synuclein gene have been identified in several families of European descent with early-onset Parkinson's disease (PD). We sequenced the complete alpha-synuclein cDNA from substantia nigra and cortex from nine patients with PD and eight control subjects. No mutations were found. We then analyzed alpha-synuclein mRNA levels using a ribonuclease protection assay. Two major protected bands of alpha-synuclein mRNA, possibly representing two splice variants of the gene, were observed. Alpha-synuclein mRNA was significantly diminished in the substantia nigra of patients with PD compared with control subjects but not in the cortex. Our findings suggest that decreased synuclein mRNA may be an early alteration in the SN in PD, and imply that decreased levels of the protein may play a role in the pathogenesis of sporadic cases of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010750 Phosphoproteins Phosphoprotein
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
June 2003, Neurochemistry international,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
October 2000, Neuroscience letters,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
November 2005, Brain : a journal of neurology,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
December 2009, Experimental neurology,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
February 2023, Molecular neurobiology,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
January 2001, Developmental neuroscience,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
April 2008, Nucleic acids research,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
December 2010, Acta neurochirurgica,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
December 2005, Neurobiology of disease,
M Neystat, and T Lynch, and S Przedborski, and N Kholodilov, and M Rzhetskaya, and R E Burke
October 2019, Cell and tissue research,
Copied contents to your clipboard!